M&A Deal Summary |
|
|---|---|
| Date | 2022-05-09 |
| Target | Eurolyser |
| Sector | Test/Measurement Equipment |
| Buyer(s) | Antech Diagnostics |
| Sellers(s) | ArchiMed |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1994 |
| Sector | Healthcare Services |
Antech Diagnostics, Inc. is an provider of health care services for animals.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 3 |
| Sector: Test/Measurement Equipment M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 2 of 2 |
| Country: Austria M&A | 1 of 1 |
| Year: 2022 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-10-23 |
Biovet
Saint-Hyacinthe, Quebec, Canada Biovet, Inc. is a biotechnology company providing unique expertise in the field of diagnostics for animal health and agro-industry specialists in Canada and internationally. Biovet is based in Saint-Hyacinthe, Quebec. |
Buy | - |
ArchiMed is a specialist French private equity firm focused on buyouts of and growth capital investments in European healthcare-oriented companies. The Firm looks to invest €10 million to €1 billion per transaction and specifically targets companies in the public health, care and wellness, biotech, and medical technology segments of the healthcare industry. ArchiMed was formed in 2014 and is headquartered in Lyon.
| DEAL STATS | # |
|---|---|
| Overall | 4 of 9 |
| Sector: Test/Measurement Equipment M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 3 of 8 |
| Country: Austria M&A | 1 of 1 |
| Year: 2022 M&A | 2 of 5 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-02-02 |
Fytexia
Vendres, France Fytexia engages in the development of innovative, ready-to-use solutions dedicated to the dietary nutrition industry and validated by extensive third-party scientific research and testing. It has developed a unique offering around a range of 5 proprietary ingredients with demonstrable efficacy supported by clinical studies which have subsequently been published as peer-reviewed articles in well-cited scientific journals. Fytexia was formed in 2003 and is based in Vendres, France. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-05-24 |
Corealis Pharma
Laval, Quebec, Canada Corealis Pharma is a provider of formulation development and clinical supply manufacturing. The company offers a spectrum of R&D services focused exclusively on pharmaceutical oral solid dosage forms (i.e. tablets, capsules, and granules) and Current Good Manufacturing Practices (cGMP) services for phase I, II and to a lesser extent, early phase III studies. COREALIS has R&D laboratories, cGMP laboratories, and phase I, II, and early phase III clinical trial manufacturing packaging suits. Corealis Pharma was founded in 2005 and is based in Laval, Quebec. |
Buy | - |
